Skip to main content

Table 3 HRs (95%CIs) for mortality according to the use of vitamin D supplement among participants with hypertension

From: Association between serum 25-hydroxyvitamin D and vitamin D dietary supplementation and risk of all-cause and cardiovascular mortality among adults with hypertension

 

Vitamin D supplementation

 

No

Yes

P-value

All-cause mortality

   

Deaths, yes (%)

1872/8481 (22.07)

1067/5785 (18.44)

 

Model 1 HR (95% CI)

1.00

1.20 (1.08–1.32)

< 0.001

Model 2 HR (95% CI)

1.00

0.65 (0.59–0.72)

< 0.001

Model 3 HR (95% CI)

1.00

0.76 (0.61–0.94)

0.01

CVD mortality

   

Deaths, yes (%)

799/8481 (9.42)

452/5785 (7.81)

 

Model 1 HR (95% CI)

1.00

1.19 (1.05–1.34)

0.32

Model 2 HR (95% CI)

1.00

0.63 (0.55–0.71)

< 0.001

Model 3 HR (95% CI)

1.00

0.75 (0.54–1.03)

0.07

  1. Abbreviations: CVD, cardiovascular disease
  2. Model 1: Unadjusted; Model 2: Adjusted for age, sex, race and survey cycle; Model 3: Adjusted for age, gender, race, survey cycle, education, PIR, BMI, smoking, drinking, during of hypertension, antihypertensive therapy and co-morbidities